Both sites take a beta-lactam programme through the same defined sequence, within their dedicated area:
- Pre-formulation: API characterisation, moisture sensitivity and excipient compatibility
- Analytical development: method development, validation and transfer
- Formulation and galenic optimisation, including paediatric and veterinary presentations
- Process development and scale-up from pilot to production scale
- Clinical supplies: clinical-stage supply through NextPharma Göttingen, the group’s principal Clinical Trials Services site
- Industrialisation: registration batches, validation, stability testing, registration services and market release with QP release in-network
Beta-lactam antibiotics can only be manufactured in facilities dedicated to their antibiotic class, and moisture-sensitive penicillins additionally require the humidity-controlled conditions NextPharma Berlin operates. Sites meeting both requirements are not widely available, which makes a mid-programme transfer more constrained than for a standard oral solid. At NextPharma Berlin and NextPharma Göttingen, development, scale-up, validation and commercial manufacture all take place inside the same dedicated area, so the process parameters and packaging configuration established during development carry into commercial batches without a change of facility, with QP release available in-network.